TDOC
Teladoc Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Sell
-33/100
Last price
5.78
▼ 0.01 (0.17%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
5.80
Prev close
5.79
Day high
5.85
Day low
5.69
Volume
3.73M
Market cap
$1.05B
P/E (TTM)
—
52W range
4.40 – 9.89
Day trading desk
Gap from prior close
+0.17%
Prior close 5.79
VWAP
5.79
-0.10% from price
Relative volume
3.43×
Unusually busy
Session range
2.90%
5.68 – 5.85
Position in range
58%
Mid range
ATR (14D)
0.22
3.82% of price
Prior day high
5.81
PDH
Prior day low
5.48
PDL
Bid / ask spread
—
Quote not published
Session volume
14.82M
Avg 4.32M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.35%
-1.6%
1M
-8.12%
-9.3%
3M
-36.38%
-40.9%
6M
+8.46%
-9.7%
YTD
-17.57%
-31.8%
1Y
-35.96%
-52.4%
3Y
-68.96%
-151.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TDOC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+229.36K
Net buying
Buy transactions
19
385.48K shares
Sell transactions
20
156.12K shares
Net transactions
+39
Buys less sells
Sell : buy shares
0.4 : 1
Mixed
Insider-held shares
1.34M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 2, 26 | CATAPANO JOSEPH RONALD Officer |
SELL | 655 | $3.70K | Direct |
| Oct 1, 26 | CATAPANO JOSEPH RONALD Officer |
— | 2.08K | — | Direct |
| Sep 11, 26 | DIVITA CHARLESIII Chief Executive Officer |
SELL | 17.80K | $108.68K | Direct |
| Sep 10, 26 | DIVITA CHARLESIII Chief Executive Officer |
— | 42.80K | — | Direct |
| Sep 3, 26 | RODRIGUES FERNANDO MADEIRA Officer |
SELL | 15.25K | $98.15K | Direct |
| Sep 2, 26 | NUENO CARLOS PLANA Officer |
SELL | 6.20K | $39.07K | Direct |
| Sep 2, 26 | BLISS KELLY Officer |
SELL | 7.36K | $46.36K | Direct |
| Sep 2, 26 | VANDERVOORT ADAM C Officer |
SELL | 7.57K | $47.72K | Direct |
| Sep 2, 26 | CATAPANO JOSEPH RONALD Officer |
SELL | 274 | $1.73K | Direct |
| Sep 2, 26 | DIVITA CHARLESIII Chief Executive Officer |
SELL | 18.33K | $115.48K | Direct |
| Sep 1, 26 | VANDERVOORT ADAM C Officer |
— | 14.93K | — | Direct |
| Sep 1, 26 | NUENO CARLOS PLANA Officer |
— | 13.27K | — | Direct |
| Sep 1, 26 | DIVITA CHARLESIII Chief Executive Officer |
— | 44.24K | — | Direct |
| Sep 1, 26 | CATAPANO JOSEPH RONALD Officer |
— | 872 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLISS KELLY |
Officer | 92.83K | Sale |
CATAPANO JOSEPH RONALD |
Officer | 14.29K | Sale |
DIVITA CHARLESIII |
Chief Executive Officer | 465.54K | Sale |
JACOBSON CATHERINE |
Director | 66.85K | Conversion of Exercise of derivative security |
MCKINLEY THOMAS G |
Director | 56.54K | Conversion of Exercise of derivative security |
MURTHY MALA |
Chief Financial Officer | 142.38K | Sale |
NUENO CARLOS PLANA |
Officer | 64.74K | Sale |
SHEDLARZ DAVID L |
Director | 61.27K | Conversion of Exercise of derivative security |
SNOW DAVID B JR |
Director | 165.03K | Conversion of Exercise of derivative security |
VANDERVOORT ADAM C |
Officer | 117.62K | Sale |
Fundamentals
Market cap$1.05B
Enterprise value$1.31B
Revenue (TTM)$2.49B
Gross profit$1.72B
EBITDA$64.56M
Net income$-177.40M
EPS (TTM)$-0.99
Free cash flow$191.04M
Total cash$774.35M
Total debt$1.04B
Book value / share$7.21
Shares outstanding181.68M
Float180.44M
Short % of float15.28%
Dividend yield0.00%
Beta (5Y)2.14
Valuation & profitability ratios
Trailing P/E—
Forward P/E-7.35
PEG ratio—
Price / sales—
Price / book0.80
EV / revenue0.53
EV / EBITDA20.29
Gross margin68.97%
Operating margin-5.68%
Profit margin-7.13%
Return on equity-12.98%
Return on assets-3.22%
Debt / equity79.09
Current ratio0.83
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.53B | $2.57B | $2.60B | $2.41B | -1.5% |
| Operating revenue | $2.09B | $2.22B | $2.28B | $2.10B | -5.6% |
| Cost of revenue | $771.59M | $751.27M | $760.03M | $743.99M | +2.7% |
| Gross profit | $1.76B | $1.82B | $1.84B | $1.66B | -3.3% |
| Research & development | $277.92M | $307.27M | $348.52M | $333.63M | -9.6% |
| Selling, general & admin | $1.28B | $1.35B | $1.37B | $1.30B | -4.9% |
| Total operating expense | $1.92B | $2.03B | $2.05B | $1.89B | -5.2% |
| Operating income | -$163.40M | -$208.79M | -$210.50M | -$227.37M | +21.7% |
| Net interest income | $17.06M | $33.27M | $24.50M | -$9.27M | -48.7% |
| Pre-tax income | -$235.53M | -$993.65M | -$219.61M | -$13.66B | +76.3% |
| Tax provision | -$35.21M | $7.59M | $760.00K | -$3.81M | -563.8% |
| Net income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Net income to common | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Basic EPS | -1.14 | -5.87 | -1.34 | -84.60 | +80.6% |
| Diluted EPS | -1.14 | -5.87 | -1.34 | -84.60 | +80.6% |
| EBIT | -$215.82M | -$969.85M | -$197.33M | -$13.64B | +77.7% |
| EBITDA | $160.62M | -$587.01M | $151.40M | -$13.37B | +127.4% |
| Basic shares | 176.22M | 170.56M | 162.17M | 161.46M | +3.3% |
| Diluted shares | 176.22M | 170.56M | 162.17M | 161.46M | +3.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Cash & short-term investments | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Accounts receivable | $192.83M | $214.15M | $217.42M | $210.55M | -10.0% |
| Inventory | $38.20M | $38.14M | $29.51M | $56.34M | +0.2% |
| Total current assets | $1.12B | $1.66B | $1.49B | $1.32B | -32.7% |
| Property, plant & equipment | $53.09M | $56.58M | $72.09M | $71.47M | -6.2% |
| Goodwill & intangibles | $1.58B | $1.71B | $2.75B | $2.91B | -7.8% |
| Total assets | $2.86B | $3.52B | $4.39B | $4.35B | -18.7% |
| Total current liabilities | $404.74M | $941.53M | $420.62M | $399.77M | -57.0% |
| Current debt | — | $550.72M | — | — | — |
| Long-term debt | $994.92M | $991.42M | $1.54B | $1.54B | +0.4% |
| Total debt | $1.04B | $1.58B | $1.59B | $1.59B | -34.4% |
| Total liabilities | $1.47B | $2.03B | $2.07B | $2.04B | -27.3% |
| Retained earnings | -$16.43B | -$16.23B | -$15.23B | -$15.01B | -1.2% |
| Shareholder equity | $1.39B | $1.49B | $2.33B | $2.31B | -7.1% |
| Working capital | $714.39M | $722.37M | $1.07B | $915.62M | -1.1% |
| Net tangible assets | -$194.57M | -$223.47M | -$424.90M | -$602.21M | +12.9% |
| Shares issued | 178.32M | 173.41M | 166.66M | 162.84M | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Depreciation & amortisation | $376.43M | $382.84M | $348.72M | $267.78M | -1.7% |
| Stock-based compensation | $80.41M | $145.95M | $201.55M | $217.85M | -44.9% |
| Change in working capital | $1.07M | -$36.31M | $11.64M | -$48.39M | +103.0% |
| Operating cash flow | $294.36M | $293.68M | $350.02M | $189.29M | +0.2% |
| Capital expenditure | -$157.02M | -$124.05M | -$156.35M | -$172.76M | -26.6% |
| Investing cash flow | -$266.00M | -$124.05M | -$156.35M | -$167.74M | -114.4% |
| Financing cash flow | -$551.65M | $8.31M | $10.85M | $6.50M | -6,736.8% |
| Free cash flow | $137.33M | $169.63M | $193.67M | $16.53M | -19.0% |
| End cash position | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $606.93M | $613.85M | $642.27M | $626.44M | $631.90M | -1.1% |
| Operating revenue | $474.21M | $484.65M | $521.60M | $520.91M | $523.70M | -2.2% |
| Cost of revenue | $190.84M | $197.53M | $197.05M | $187.18M | $190.54M | -3.4% |
| Gross profit | $416.09M | $416.32M | $445.22M | $439.26M | $441.36M | -0.1% |
| Research & development | $62.86M | $67.86M | $71.61M | $67.57M | $68.78M | -7.4% |
| Selling, general & admin | $296.82M | $304.90M | $305.74M | $318.77M | $325.61M | -2.6% |
| Total operating expense | $450.59M | $465.05M | $472.19M | $474.72M | $487.40M | -3.1% |
| Operating income | -$34.50M | -$48.73M | -$26.97M | -$35.46M | -$46.03M | +29.2% |
| Net interest income | $1.37M | $1.12M | $2.00M | $2.56M | $5.59M | +22.3% |
| Pre-tax income | -$37.91M | -$60.84M | -$33.62M | -$50.22M | -$40.42M | +37.7% |
| Tax provision | $997.00K | $3.00M | -$8.47M | -$715.00K | -$7.76M | -66.7% |
| Net income | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Net income to common | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Basic EPS | -0.21 | -0.36 | -0.14 | -0.28 | -0.19 | +41.7% |
| Diluted EPS | -0.21 | -0.36 | -0.14 | -0.28 | -0.19 | +41.7% |
| EBIT | -$32.80M | -$55.47M | -$28.67M | -$45.70M | -$35.95M | +40.9% |
| EBITDA | $59.60M | $38.71M | $70.55M | $46.46M | $58.94M | +54.0% |
| Basic shares | 181.03M | 179.12M | 177.83M | 176.93M | 175.92M | +1.1% |
| Diluted shares | 181.03M | 179.12M | 177.83M | 176.93M | 175.92M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | — | +3.1% |
| Cash & short-term investments | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | — | +3.1% |
| Accounts receivable | $221.01M | $213.63M | $192.83M | $210.76M | $225.43M | — | +3.5% |
| Inventory | $28.82M | $31.56M | $38.20M | $39.90M | $38.16M | — | -8.7% |
| Total current assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | — | +1.4% |
| Property, plant & equipment | $47.41M | $50.51M | $53.09M | $59.28M | $53.17M | — | -6.1% |
| Goodwill & intangibles | $1.46B | $1.52B | $1.58B | $1.62B | $1.67B | — | -3.9% |
| Total assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | — | -1.7% |
| Total current liabilities | $1.38B | $404.87M | $404.74M | $405.09M | $401.77M | — | +241.3% |
| Current debt | $996.70M | — | — | — | — | $550.72M | — |
| Long-term debt | — | $995.81M | $994.92M | $994.04M | $993.16M | $992.29M | — |
| Total debt | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | — | -0.2% |
| Total liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | — | -1.5% |
| Retained earnings | -$16.53B | -$16.49B | -$16.43B | -$16.41B | -$16.36B | — | -0.2% |
| Shareholder equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | — | -2.0% |
| Working capital | -$233.37M | $727.47M | $714.39M | $687.67M | $671.50M | — | -132.1% |
| Net tangible assets | -$148.75M | -$182.06M | -$194.57M | -$227.73M | -$244.36M | — | +18.3% |
| Shares issued | 181.65M | 180.43M | 178.32M | 177.35M | 176.61M | — | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Depreciation & amortisation | $92.41M | $94.19M | $99.22M | $92.15M | $94.89M | -1.9% |
| Stock-based compensation | $9.30M | $14.61M | $15.91M | $17.00M | $22.34M | -36.3% |
| Change in working capital | $107.00K | -$35.63M | $4.10M | $24.01M | $13.45M | +100.3% |
| Operating cash flow | $64.66M | $9.52M | $87.74M | $99.26M | $91.43M | +579.5% |
| Capital expenditure | -$41.59M | -$35.82M | -$34.32M | -$31.32M | -$59.80M | -16.1% |
| Investing cash flow | -$41.59M | -$36.52M | -$34.32M | -$48.72M | -$59.70M | -13.9% |
| Financing cash flow | $875.00K | -$2.45M | $1.10M | -$3.59M | -$549.93M | +135.7% |
| Free cash flow | $23.07M | -$26.31M | $53.42M | $67.95M | $31.63M | +187.7% |
| End cash position | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | +3.1% |
Options analytics
Put / call volume
6.86
Put-heavy session
Put / call open interest
0.17
Positioning, not flow
Max pain
5.50
-4.7% from spot
ATM implied vol
57.8%
Nearest strike to spot
Skew (10% OTM)
+43.8%
Puts bid over calls
Call volume
146
Contracts, this expiry
Put volume
1.00K
Contracts, this expiry
Heaviest call OI
6.50
1.98K contracts
Heaviest put OI
6.00
380 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.23 | -0.20 | +10.8% |
| Mar 2026 | -0.39 | -0.28 | +26.7% |
| Dec 2025 | -0.22 | -0.10 | +52.1% |
| Sep 2025 | -0.31 | -0.19 | +38.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.19 | 3 | $592.31M | -5.5% |
| Next quarter | -0.09 | 3 | $602.02M | -6.3% |
| Current year | -0.79 | 3 | $2.42B | -4.3% |
| Next year | -0.72 | 3 | $2.40B | -1.0% |
Analyst targets & ownership
Mean target$7.59
High target$10.50
Low target$5.50
Implied upside31.28%
Analyst count17
ConsensusHOLD
Strong buy / Buy1 / 5
Hold17
Sell / Strong sell0 / 0
Held by insiders0.74%
Held by institutions86.83%
Institutions holding469
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.86
-1.28% from price
SMA 20
6.08
-5.11% from price
SMA 50
6.48
-11.00% from price
SMA 100
7.25
-20.24% from price
SMA 200
6.55
-11.90% from price
EMA 12
5.89
-1.93% from price
EMA 26
6.14
-5.90% from price
EMA 50
6.50
-11.12% from price
RSI (14)
38.4
Neutral
MACD (12,26,9)
-0.25
Hist -0.01
ATR (14)
0.22
3.83% of price
Realised vol 30D
35.8%
Annualised
Bollinger upper
6.65
20, 2σ
Bollinger lower
5.51
20, 2σ
50 / 200 cross
Death
6.48 vs 6.55
Trend bias
Below 200
-11.90%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.20
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
35.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-52.7%
Peak to trough
Max drawdown 5Y
-97.1%
Peak to trough
ATR 14
0.22
3.83% of price
Beta (reported)
2.14
5Y monthly, from filing
Short interest
Shares short
27.63M
Prior 23.69M
Change vs prior
+16.6%
Shorts adding
% of float
15.28%
Elevated
% of shares out
15.21%
Against total outstanding
Days to cover
8.1
Crowded exit
Float
180.44M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 7, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| May 5, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 8, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Mar 26, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 13, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Mar 10, 26 | Deutsche Bank | UPGRADE | Hold | Buy |
| Mar 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Mar 3, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-25
Corporate Changes & Voting Matters
8-K · 2026-08-31
Corporate Changes & Voting Matters
8-K · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-03
Periodic Financial Reports
10-Q · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-07-29
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-21
Headlines
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks · 7d ago
Reddit and Teladoc Shares Plummet, What You Need To Know
StockStory · 8d ago
Evergreen Nephrology Appoints Brian Palo as Chief Financial Officer
PR Newswire · 9d ago
Connected Health & Safety Association Annual Conference Highlights Industry Growth and the Future of Connected Care
PR Newswire · 12d ago
Teladoc Health Announces Chief Legal Officer Transition
GlobeNewswire · 12d ago
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
Trefis · 13d ago
3 Small-Cap Stocks We Find Risky
StockStory · 13d ago
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.